Stocks In Play


(MENAFN- Baystreet) Northwest Healthcare Properties Real Estate Invest
5/15/2024 10:35 AM EST

  • Chartwell Retirement Residences
    5/15/2024 10:28 AM EST
  • Thomson Reuters
    5/15/2024 10:06 AM EST
  • Probe Gold
    Inc.

    5/15/2024 10:00 AM EST
  • Obsidian Energy Ltd.
    5/15/2024 9:57 AM EST
  • Intermap Technologies
    5/15/2024 9:51 AM EST
  • Bridgemarq Real Estate Services Inc.

    5/15/2024 9:47 AM EST
  • TERAGO Inc.

    5/15/2024 9:42 AM EST
  • Bee Vectoring Technologies International Inc
    5/15/2024 9:25 AM EST
  • Oncolytics Biotech Inc
    5/15/2024 9:21 AM EST Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkin - Wednesday, May 15, 2024

    Stocks in Play

    5/15/2024 - 11:54 AM EST - Microbix Biosystems Inc.
    :
    Reports results for its second quarter and first half of fiscal 2024 ended March 31. Q2 revenue was $5,632,901, a 34% increase from Q2 2023 revenues of $4,218,323. Increased sales and higher gross margin dollars led to an operating income and net income of $377,730 versus a Q2 2023 operating income and net income of $31,616. Microbix Biosystems Inc.
    shares T are trading up $0.02 at $0.34.





    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks

    MENAFN15052024000212011056ID1108218398


  • Baystreet.ca

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.